Cargando…
Newborn screening for medium chain acyl-CoA dehydrogenase deficiency in England: prevalence, predictive value and test validity based on 1.5 million screened babies
BACKGROUND: Medium chain acyl-CoA dehydrogenase deficiency (MCADD) is a rare, life-threatening condition. Early diagnosis by screening asymptomatic newborns may improve outcome, but the benefit to newborns identified with variants not encountered clinically is uncertain. OBJECTIVE: To estimate, over...
Autores principales: | Oerton, Juliet, Khalid, Javaria M, Besley, Guy, Dalton, R Neil, Downing, Melanie, Green, Anne, Henderson, Mick, Krywawych, Steve, Leonard, James, Andresen, Brage S, Dezateux, Carol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Medicine Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3243649/ https://www.ncbi.nlm.nih.gov/pubmed/22166308 http://dx.doi.org/10.1258/jms.2011.011086 |
Ejemplares similares
-
FLAD1‐associated multiple acyl‐CoA dehydrogenase deficiency identified by newborn screening
por: Muru, Kai, et al.
Publicado: (2019) -
Maternal vitamin deficiency mimicking multiple acyl-CoA dehydrogenase deficiency on newborn screening
por: Gramer, Gwendolyn, et al.
Publicado: (2021) -
The first three years of screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) by newborn screening ontario
por: Kennedy, Shelley, et al.
Publicado: (2010) -
Cost-effectiveness analysis of universal newborn screening for medium chain acyl-CoA dehydrogenase deficiency in France
por: Hamers, Françoise F, et al.
Publicado: (2012) -
Cardiac Hypertrophy in Mice with Long-Chain Acyl-CoA Dehydrogenase (LCAD) or Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency
por: Cox, Keith B., et al.
Publicado: (2009)